Dr. Tom Keenan is an award-winning journalist, public speaker, professor in the School of Architecture, Planning and ...

The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, ...

"We are advancing our SERENITY At-Home trial to pursue the near-term growth opportunity for treating acute agitation ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

This advertisement has not loaded yet, but your article continues below.

This advertisement has not loaded yet, but your article continues below.

The news of the day as interpreted by our talented artists, illustrators and cartoonists.

You can find this story in My Bookmarks.Or by navigating to the user icon in the top right.